1Valdezate S, Vindel A, Echeita A, et al. Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility. Antimicrob Agents Chemother, 2002,46(3): 665-671
2Valdezate S,Vindel A, Loza E, et al. Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains. Antimicrob Agents Chemother,2001,45(5): 1581-1584.
3Payne DJ,Cramp R,Bateson JH,et al. Rapid identification of metallo- and serine beta-lactamases. Antimicrob Agents Chemother,1994,38(5) :991-996.
4Walsh TR,MacGowan AP,Bennett PM. Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia. Antimicrob Agents Chemother, 1997,41 (7):1460-1464.
5Paton R,Miles RS, Amyes SG. Biochemical properties of inducible beta-lactamases produced from Xanthomonas maltophilia. Antimierob Agents Chemotber, 1994,38(9):2143-2149.
